Track Johnson & Johnson — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Johnson & Johnson JNJ.F · Stock Open Johnson & Johnson in new tab

233.65 EUR
P/E
31.56
EPS
7.46
Yield
2.33%
P/B
7.70
ROE
25.74
Beta
0.24
Loading chart...
Key Metrics
P/E31.56
EPS7.46
Book Value30.58
Price to Book7.70
Debt/Equity57.71
% Insiders0.053%
Growth
Revenue Growth0.07%
Earnings Growth-0.01%
Dividend
Dividend Yield2.33%
Annual dividends4.59 EUR
Ex-Div. DateAug. 25, 2026
Payout60.25%
5y avg Yield2.77%

DCF Valuation

Tweak assumptions to recompute fair value for Johnson & Johnson (JNJ.F)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Johnson & Johnson Logo Johnson & Johnson Analysis (JNJ.F)

United States Health Care Official Website Stock

Is Johnson & Johnson a good investment? Johnson & Johnson (JNJ.F) is currently trading at 233.65 EUR.

In terms of valuation, the stock trades at a P/E ratio of 31.56. This high multiple suggests investors have priced in significant future growth expectations.

For income investors, Johnson & Johnson pays a dividend yield of 2.33%. With a payout ratio of 60%, the dividend appears sustainable.

Investor FAQ

Does Johnson & Johnson pay a dividend?

Yes, it pays an annual dividend of 4.59 EUR (2.33% yield).

What asset class is Johnson & Johnson?

Johnson & Johnson is classified as a Stock. You can compare it against 12 other assets in the "Related Symbols" list on this page.

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Exchange Ticker
BUE (Argentina) DJNJ2.BA
SGO (Chile) JNJ.SN
VIE (Austria) JNJ.VI
SGO (Chile) JNJCL.SN
US4781601046
BUE (Argentina) DJNJ3.BA
GER (Germany) JNJ.DE
NYQ (United States) JNJ
MEX (Mexico) JNJ.MX
STU (Germany) JNJ.SG
SAO (Brazil) JNJB34.SA
FRA (Germany) JNJ.F
Trades
Dividend Yield
2.33%
5y avg 2.77%
Annual Dividends
4.59EUR
Next Ex. Div Date
Aug. 25, 2026
Payout Ratio
60.25%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2027
3.54 EUR
Aug. 24, 2027 (estimated) 1.2108
June 22, 2027 (estimated) 1.1503
Feb. 23, 2027 (estimated) 1.1806
2026
4.59 EUR
Nov. 24, 2026 (estimated) 1.1747
Aug. 25, 2026 1.1503
June 9, 2026 1.1503
Feb. 24, 2026 1.1159
2025
4.41 EUR
Nov. 25, 2025 1.1159
Aug. 26, 2025 1.1159
May 27, 2025 1.1159
Feb. 18, 2025 1.0644
2024
4.21 EUR
Nov. 26, 2024 1.0644
Aug. 27, 2024 1.0644
May 20, 2024 1.0644
Feb. 16, 2024 1.0215
2023
4.03 EUR
Nov. 20, 2023 1.0215
Aug. 25, 2023 1.0215
May 22, 2023 1.0215
Feb. 17, 2023 0.9700
2022
3.82 EUR
Nov. 21, 2022 0.9700
Aug. 22, 2022 0.9700
May 23, 2022 0.9700
Feb. 18, 2022 0.9099
2021
3.60 EUR
Nov. 22, 2021 0.9099
Aug. 23, 2021 0.9099
May 25, 2021 0.9099
Feb. 22, 2021 0.8670
2020
3.42 EUR
Nov. 23, 2020 0.8670
Aug. 24, 2020 0.8670
May 22, 2020 0.8670
Feb. 24, 2020 0.8155
2019
3.22 EUR
Nov. 25, 2019 0.8155
Aug. 26, 2019 0.8155
May 24, 2019 0.8155
Feb. 25, 2019 0.7726
2018
3.04 EUR
Nov. 26, 2018 0.7726
Aug. 27, 2018 0.7726
May 25, 2018 0.7726
Feb. 26, 2018 0.7211
2017
2.13 EUR
Nov. 27, 2017 0.7211
Aug. 25, 2017 0.7211
Feb. 24, 2017 0.6867
2016
2.70 EUR
Nov. 18, 2016 0.6867
Aug. 19, 2016 0.6867
May 20, 2016 0.6867
Feb. 19, 2016 0.6438
2015
2.53 EUR
Nov. 20, 2015 0.6438
Aug. 21, 2015 0.6438
May 21, 2015 0.6438
Feb. 20, 2015 0.6009
2014
2.37 EUR
Nov. 21, 2014 0.6009
Aug. 22, 2014 0.6009
May 22, 2014 0.6009
Feb. 21, 2014 0.5665
2013
2.22 EUR
Nov. 22, 2013 0.5665
Aug. 23, 2013 0.5665
May 23, 2013 0.5665
Feb. 22, 2013 0.5236
2012
2.06 EUR
Nov. 23, 2012 0.5236
Aug. 24, 2012 0.5236
May 24, 2012 0.5236
Feb. 24, 2012 0.4893
2011
1.93 EUR
Nov. 25, 2011 0.4893
Aug. 26, 2011 0.4893
May 26, 2011 0.4893
Feb. 25, 2011 0.4635
2010
0.46 EUR
Nov. 26, 2010 0.4635
Upcoming Dividends
Name Payment Date Status Amount
Johnson & Johnson Aug 25, 2026 1.150256 EUR
Johnson & Johnson Jun 09, 2026 1.150256 EUR
Johnson & Johnson Feb 24, 2026 1.11592 EUR
Johnson & Johnson Nov 25, 2025 1.11592 EUR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion